Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6949746 | 0.83 | PLA2G7 (0.47) | PLA2G7 | |
| SCHEMBL6947739 | 0.81 | PLA2G7 (0.52) | PLA2G7 | |
| SCHEMBL6947323 | 0.79 | PLA2G7 (0.43) | PLA2G7 | |
| SCHEMBL7221064 | 0.75 | PLA2G7 (0.46) | PLA2G7 | |
| SCHEMBL7008378 | 0.75 | PLA2G7 (0.47) | PLA2G7 | |
| SCHEMBL6951481 | 0.75 | PLA2G7 (0.44) | PLA2G7 | |
| SCHEMBL6951245 | 0.75 | PLA2G7 (0.50) | PLA2G7 | |
| SCHEMBL6954832 | 0.75 | PLA2G7 (0.58) | PLA2G7 | |
| SCHEMBL6949723 | 0.75 | PLA2G7 (0.51) | PLA2G7 | |
| SCHEMBL6947762 | 0.75 | PLA2G7 (0.51) | PLA2G7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1105377-B1 | PYRIMIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS | SMITHKLINE BEECHAM PLC (GB) | 2003-10-08 | — | — | EP | claimed |
| US-6559155-B1 | Phospholipase A2 enzyme Lipoprotein Associated Phospholipase A2 inhibitors | SMITHKLINE BEECHAM P.L.C. (GB) | 2003-05-06 | — | — | US | claimed |
| EP-1105377-A1 | PYRIMIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS | SMITHKLINE BEECHAM PLC (GB) | 2001-06-13 | — | — | EP | claimed |
| WO-2000010980-A1 | PYRIMIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS | SMITHKLINE BEECHAM PLC (GB) | 2000-03-02 | — | — | WO | claimed |
| US-6559155-B1 | Phospholipase A2 enzyme Lipoprotein Associated Phospholipase A2 inhibitors | SMITHKLINE BEECHAM P.L.C. (GB) | 2003-05-06 | — | — | US | disclosed |